Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001816338-21-000001
Filing Date
2021-12-17
Accepted
2021-12-17 15:14:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 anderson13ga.txt SC 13G/A 2522
  Complete submission text file 0001816338-21-000001.txt   3853
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Subject) CIK: 0001738021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90878 | Film No.: 211501201
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 44 SOUTH MAIN STREET 3RD FLOOR HANOVER NH 03755
Business Address
ANDERSON ERRIK (Filed by) CIK: 0001816338 (see all company filings)

Type: SC 13G/A